Medication Assisted Treatment for Opioid Dependence to Reduce the Risk of Death by Suicide
2019 Standard Research Grant
Amount Awarded: $99,468
Focus Area: Clinical Treatment Studies
Bradley Watts, M.D., M.P.H.
There is a 13 times higher rate of death by suicide in people with opioid use disorder (OUD) as compared to the general population. Medication-assisted treatment (MAT) for opioid dependence is a standard part of treatment. By examining medical records and pharmacy data linked with death records of a large group of patients treated with MAT in the Department of Veterans Affairs (VA), this study will examine whether MAT is associated with reduced suicide deaths among opioid users.